NYXH
Nyxoah S.A.
1W: +3.6%
1M: -25.8%
3M: -33.3%
YTD: -29.6%
1Y: -72.0%
3Y: -49.2%
$3.17
-0.02 (-0.63%)
After Hours: $3.13 (-0.04, -1.10%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$118.4M
52W Range3.02-11.87
Volume62,842
Avg Volume51,581
Beta0.62
Dividend—
Analyst Ratings
Company Info
CEOOlivier Taelman
Employees183
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2021-04-28
Websitenyxoah.com
Rue Edouard Belin 12
Mont-Saint-Guibert 1435
BE
Mont-Saint-Guibert 1435
BE
32 1 022 23 55
About Nyxoah S.A.
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Recent Insider Trades
No insider trades found